Lixte Biotechnology Holdings, I (LIXTW) Financials

LIXTW Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 4.3 million 313858
2023-09-30 5.2 million 311736
2023-06-30 3.1 million 402614
2023-03-31 4.3 million 249987

LIXTW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -902123 104057
2023-09-30 -944389 112106
2023-06-30 -1.2 million 280060
2023-03-31 -1.3 million 276980

LIXTW Net Income

No data available :(

LIXTW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 5.1 million - -
2023-06-30 2.9 million - -
2023-03-31 4.1 million - -

LIXTW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.2 million
2023-09-30 2.1 million
2023-06-30 1.7 million
2023-03-31 1.7 million

LIXTW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 149071 876839 -
2023-09-30 - 132487 534013 -
2023-06-30 - 427457 862571 -
2023-03-31 - 189085 1.2 million -

LIXTW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -

LIXTW

Price: $0.05

52 week price:
0.03
0.14

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1400

Market Capitalization: 39.5 million

Links: